Pathstone Holdings
CVS icon

Pathstone Holdings’s CVS Health CVS Stock Holding History

Pathstone Holdings’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.8M Buy
181,276
+11,979
+7% +$1.07M 0.05% 225
2026
Q1 		$12.2M Sell
169,297
-12,628
-7% -$973K 0.05% 282
2025
Q4 		$14.4M Buy
181,925
+1,149
+0.6% +$90.6K 0.06% 235
2025
Q3 		$13.6M Buy
180,776
+973
+0.5% +$66.7K 0.05% 248
2025
Q2 		$12.4M Buy
179,803
+16,668
+10% +$1.09M 0.05% 265
2025
Q1 		$11.1M Sell
163,135
-26,739
-14% -$1.6M 0.05% 305
2024
Q4 		$8.53M Sell
189,874
-32,411
-15% -$1.82M 0.04% 369
2024
Q3 		$14M Buy
222,285
+4,432
+2% +$259K 0.06% 227
2024
Q2 		$12.9M Sell
217,853
-31,098
-12% -$1.95M 0.06% 239
2024
Q1 		$19.9M Buy
248,951
+38,489
+18% +$2.94M 0.09% 155
2023
Q4 		$16.6M Buy
+210,462
New +$15M 0.09% 165

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Pathstone Holdings's CVS Position: Q2 2026 in Review

Pathstone Holdings increased its CVS Health (CVS) stake by 7.1% in Q2 2026, buying an estimated $1.07M and bringing the position to 181,276 shares worth $18.8M. The position accounts for 0.05% of the portfolio, ranked #225.

Pathstone Holdings first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $19.9M in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Pathstone Holdings held 181,276 shares of CVS Health worth $18.8M as of Q2 2026.
  • Pathstone Holdings bought 11,979 CVS Health shares in Q2 2026, an estimated $1.07M.
  • CVS Health made up 0.05% of Pathstone Holdings's portfolio in Q2 2026, its #225 holding.
  • Pathstone Holdings first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's CVS Health position peaked at $19.9M in Q1 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.